Mercato chiuso -
Altri mercati azionari
|
Variaz. 5gg | Var. 1 gen. | ||
7,82 USD | -3,22% | -1,26% | -31,64% |
Attività
Numero di dipendenti: 267
Vendite per attività
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
Collaborative Arrangements
100,0
%
| 411 | 100,0 % | 443 | 100,0 % | +7,83% |
Vendite per regione
USD in Milioni | 2022 | Peso | 2023 | Peso | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 411 | 100,0 % | 443 | 100,0 % | +7,83% |
Dirigenti
Dirigenti | Titolo | Età | Da |
---|---|---|---|
Thomas McCourt
CEO | Chief Executive Officer | 66 | 01/01/09 |
Sravan Emany
DFI | Director of Finance/CFO | 46 | 06/12/21 |
Marcel Moulaison
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/14 |
Chief Tech/Sci/R&D Officer | 65 | 28/01/19 | |
Greg Martini
IRC | Investor Relations Contact | - | 01/06/17 |
Susanna H. Huh
PRN | Corporate Officer/Principal | - | 01/09/22 |
Mike Nanfito
SAM | Sales & Marketing | - | 01/05/12 |
John Minardo
LAW | General Counsel | 49 | 03/08/21 |
Ronald Silver
AUD | Comptroller/Controller/Auditor | 42 | 01/06/18 |
Andrew Davis
PRN | Corporate Officer/Principal | 38 | 01/05/21 |
Amministratori
Amministratori | Titolo | Età | Da |
---|---|---|---|
Alexander Denner
BRD | Director/Board Member | 54 | 09/11/20 |
Jay Shepard
BRD | Director/Board Member | 66 | 03/12/20 |
Mark Currie
BRD | Director/Board Member | 69 | 01/01/20 |
Andrew Dreyfus
BRD | Director/Board Member | 65 | 01/04/16 |
Thomas McCourt
CEO | Chief Executive Officer | 66 | 01/01/09 |
Director/Board Member | 64 | 01/04/19 | |
Julie McHugh
CHM | Chairman | 59 | 01/02/14 |
Jon Duane
BRD | Director/Board Member | 65 | 01/04/19 |
Marla Kessler
BRD | Director/Board Member | 54 | 01/04/19 |
Classe di azioni
Voto | Quantità | Flottante | Autocontrollo | Flottante totale | |
---|---|---|---|---|---|
Azione A | 10 | 158 957 123 | 153 278 890 ( 96,43 %) | 0 | 96,43 % |
Coordinate società
Ironwood Pharmaceuticals, Inc.
100 Summer Street Suite 2300
02110, Boston
+617 621 7722
http://www.ironwoodpharma.comSettore
Revisioni EPS
Variaz. 1 gen. | Capi. | |
---|---|---|
-31,64% | 1,24 Mrd | |
+1,51% | 42,75 Mrd | |
+49,22% | 41,61 Mrd | |
+8,57% | 41,34 Mrd | |
-12,36% | 26,59 Mrd | |
+8,92% | 25,49 Mrd | |
-25,13% | 18,12 Mrd | |
+29,17% | 12,24 Mrd | |
-3,12% | 11,76 Mrd | |
+6,35% | 11 Mrd |
- Borsa valori
- Azioni
- Azione IRWD
- Società Ironwood Pharmaceuticals, Inc.